nova

Which Diabetes Drugs Will Win Out?

I agree there is nothing wrong with "me-too". So far, we have somewhat free-market system.

Consequently, drug companies must have freedom developing drugs they feel are appropriate. Some competition is good for everyone: companies and patients.

At the same time, in America, we have a major problem with the FDA:
- They are not either consistent or objective in the drug evaluation process and being too much influenced by "special" interests
- Very often, the FDA approves drugs without any clinical benefits to patients
- Finally, but not last, the FDA provide avenues for drugs comparative studies giving physicians and patients opportunities to make intelligent choices selecting the most appropriate drugs

In any case, the best marketing should not be a guidance for selecting the most appropriate treatment drug(s) for specific patients.